Earlier this year, we held the first in-person #RECOVERYtrial UK collaborators meeting where we spoke to some of the hospital staff who recruited and cared for patients.
Thank you to everyone involved! ➡️
RECOVERY logo
Hospitalisations for flu are very high for this time of year.
The #RECOVERYtrial was vital in identifying treatments for COVID-19.
Now, RECOVERY is investigating the effectiveness of three existing drugs against other forms of pneumonia, including influenza ➡️ buff.ly/4LElSiJ
Good news! The #RECOVERYTrial team, co-led by PSI Oxford's Professor Sir @peterhorby.bsky.social, have just won a @nihr.bsky.social Impact Prize for their major impact on the health and wellness of the nation. Congratulations team 🏆🎉💉
Find out more 👉 buff.ly/jmYSJWI
Dr Raha West receiving the #NIHRImpactPrizes established investigator prize on behalf of the RECOVERY Trial
The judging panel of the #NIHRImpactPrizes described RECOVERY as ‘One of the most well-known studies supported by the NIHR with clear national and global impact.’
Read the full news article on the #RECOVERYtrial website here. 👉 buff.ly/zHJMF0a
The #NIHRImpactPrizes chose the #RECOVERYtrial as one of their established investigator prize winners!
Thank you to everyone who made the trial possible and congratulations to all the winners!
Find out more about how the trial was first established. 👉 buff.ly/QCtBuLQ
Dr Raha West will be representing the #RECOVERYtrial at the #NIHRImpactPrizes ceremony this evening.
Read about her journey from Buckinghamshire to worldwide impact on the trial website. 👉 buff.ly/P7Mcrqz
Congratulations to all the finalists! 🎉
Social media card with details of the RECOVERY trial's website: recoverytrial.net
Today marks five years since the first patients were recruited into the #RECOVERYTrial which found five effective treatments for people hospitalised with #COVID-19.
RECOVERY now has over 50,000 participants and continues its work finding treatments for community-acquired pneumonia and flu. 💊
The #RECOVERYTrial has now recruited 50,000 participants! 🎉
Set up in the UK in March 2020, RECOVERY has evaluated treatments for COVID-19, community acquired pneumonia (CAP), and flu.
RECOVERY is now open to people in hospital with CAP and flu at sites across Europe, Asia, and Africa.
‘As well as being the greatest pandemic risk, influenza remains a serious annual scourge. In a bad year, as many as 25,000 people in the UK die as a result of influenza. Yet we have no treatments that are proven to improve outcomes in hospitalised influenza patients. By including influenza in the RECOVERY trial, we have the opportunity to change this and find new treatments for this persistent menace.’ Professor Sir Peter Horby Moh Family Foundation Professor of Emerging Infections and Global Health Joint Chief Investigator for the RECOVERY trial
See what Professor Sir @peterhorby.bsky.social, Joint Chief Investigator for the #RECOVERYTrial said below 👇
@medsci.ox.ac.uk @ox.ac.uk
‘RECOVERY was designed to provide a robust test of possible treatments for COVID-19 whilst keeping the burden on hospital staff and the health system to a minimum. This approach led to the discovery of effective treatments for COVID-19, such as dexamethasone, which have now saved hundreds of thousands of lives around the world. We are now expanding this approach to tackle the long-term challenge of influenza.’ Professor Sir Martin Landray Professor of Medicine and Epidemiology Joint Chief Investigator of the RECOVERY trial
Professor Sir @martinlandray.bsky.social, Joint Chief Investigator for RECOVERY, explains what makes the #RECOVERYTrial appropriate for investigating flu treatments below. 😷👇
@medsci.ox.ac.uk @ox.ac.uk @ndm.ox.ac.uk
Effective COVID-19 treatments: dexamethasone, tocilizumab, ronapreve, baricitinib. Treatments that do not benefit COVID-19 patients: hydroxychloroquine, lopinavir-ritonavir, azithromycin, convalescent plasma, asprin, colchincine, dimethyl fumarate, higher dose corticosteroids, empagliflozin.
The #RECOVERYTrial started in the UK in early 2020 as a clinical trial testing treatments for people admitted to hospital with #COVID-19 pneumonia. Since then it has identified four life-saving treatments for COVID-19, and shown that several other commonly used treatments were not effective.
5,408 patients in hospital in the UK with flu each day during the first week of 2025.
Seasonal #flu epidemics are estimated to kill over 290,000 people every year, with very few clinical trials evaluating effective treatments for severe flu. In October 2023, the #RECOVERYTrial expanded to investigate treatments for flu. Learn more below. 👇🧵
'It is crucial the UK is prepared for the arrival of future pandemics. You don’t get ready to fight the next war by disbanding the army just because it’s peacetime.'
@MartinLandray @Oxford_NDPH #RECOVERYTrial @PeterHorby @RobinMcKie @guardian @ObserverUK
www.theguardian.com/world/2024/m...
Over 1 in 4 #COVID19 patients at @MFT_MRI agreed to take part since 4th Jan, and theretore to help us all learn more about this disease.
#Recoverytrial
@PeterHorby @MartinLandray @mftchiefnurse @MFTPgrad @MRI_ED
167 patients recruited to #RECOVERYtrial at @MFTnhs since 4th Jan :-) :-) :-)
Great to see more #Recoverytrial output in @TheLancet today
Very grateful to patients for taking part and staff for helping it happen.
@PeterHorby @MartinLandray @mftchiefnurse @MFTPgrad @MRI_ED
L'association #lopinavir #ritonavir ne marche pas dans la #Covid_19 .
Avec des IC50 de 10 µM dans le (mauvais) modèle des cellules vero et 20 µM sur cellule humaine... il n'y avait aucune chance
C'était annoncé en juillet.. c'est publié #recoverytrial
thelancet.com/journals/lance…
#recoverytrial renal outcomes analysis ongoing seems like - covid19 use of dexamethasone www.nejm.org/doi/full/10.1056/NEJMoa2...
This is the happy face of someone who has not only be redeployed to @MTW_Research for the #recoverytrial but has had her first @CostaCoffee since lockdown.....